{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:41:59Z","timestamp":1794966119450,"version":"4.9.1"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1038\/s41584-023-01057-6","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T05:02:42Z","timestamp":1702875762000},"page":"158-169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":187,"title":["Epidemiology of Sj\u00f6gren syndrome"],"prefix":"10.1038","volume":"20","author":[{"given":"Maxime","family":"Beydon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0866-3824","authenticated-orcid":false,"given":"Yann","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Sumida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Mariette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5523-1856","authenticated-orcid":false,"given":"Rapha\u00e8le","family":"Seror","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,18]]},"reference":[{"key":"1057_CR1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMcp1702514","volume":"378","author":"X Mariette","year":"2018","unstructured":"Mariette, X. & Criswell, L. A. Primary Sj\u00f6gren\u2019s syndrome. N. Engl. J. Med. 378, 931\u2013939 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1057_CR2","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/art.21990","volume":"55","author":"J Champey","year":"2006","unstructured":"Champey, J. et al. Quality of life and psychological status in patients with primary Sj\u00f6gren\u2019s syndrome and sicca symptoms without autoimmune features. Arthritis Rheum. 55, 451\u2013457 (2006).","journal-title":"Arthritis Rheum."},{"key":"1057_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-018-1715-x","volume":"18","author":"Y Cui","year":"2018","unstructured":"Cui, Y. et al. Anxiety and depression in primary Sj\u00f6gren\u2019s syndrome: a cross-sectional study. BMC Psychiatry 18, 131 (2018).","journal-title":"BMC Psychiatry"},{"key":"1057_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jbspin.2015.10.005","volume":"83","author":"M Milin","year":"2016","unstructured":"Milin, M. et al. Sicca symptoms are associated with similar fatigue, anxiety, depression, and quality-of-life impairments in patients with and without primary Sj\u00f6gren\u2019s syndrome. Jt. Bone Spine 83, 681\u2013685 (2016).","journal-title":"Jt. Bone Spine"},{"key":"1057_CR5","first-page":"1552","volume":"30","author":"J Font","year":"2003","unstructured":"Font, J. et al. Pure sensory neuropathy in primary Sj\u00f6gren\u2019s syndrome. Longterm prospective followup and review of the literature. J. Rheumatol. 30, 1552\u20131557 (2003).","journal-title":"J. Rheumatol."},{"key":"1057_CR6","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1093\/rheumatology\/keab364","volume":"60","author":"H Huang","year":"2021","unstructured":"Huang, H., Xie, W., Geng, Y., Fan, Y. & Zhang, Z. Mortality in patients with primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis. Rheumatology 60, 4029\u20134038 (2021).","journal-title":"Rheumatology"},{"key":"1057_CR7","first-page":"102","volume":"112","author":"P Brito-Zer\u00f3n","year":"2018","unstructured":"Brito-Zer\u00f3n, P. et al. How immunological profile drives clinical phenotype. Clin. Exp. Rheumatol. 112, 102\u2013112 (2018).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1057_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059868","volume":"8","author":"J-E Gottenberg","year":"2013","unstructured":"Gottenberg, J.-E. et al. Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sj\u00f6gren\u2019s syndrome. Data at enrollment in the prospective ASSESS cohort. PLoS ONE 8, e59868 (2013).","journal-title":"PLoS ONE"},{"key":"1057_CR9","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/rheumatology\/kes180","volume":"52","author":"L Quartuccio","year":"2013","unstructured":"Quartuccio, L. et al. BLyS upregulation in Sj\u00f6gren\u2019s syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands. Rheumatology 52, 276\u2013281 (2013).","journal-title":"Rheumatology"},{"key":"1057_CR10","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/rheumatology\/keaa009","volume":"59","author":"F Kollert","year":"2020","unstructured":"Kollert, F. & Fisher, B. A. Equal rights in autoimmunity: is Sj\u00f6gren\u2019s syndrome ever \u2018secondary\u2019? Rheumatology 59, 1218\u20131225 (2020).","journal-title":"Rheumatology"},{"key":"1057_CR11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3899\/jrheum.180392","volume":"46","author":"CP Mavragani","year":"2019","unstructured":"Mavragani, C. P. & Moutsopoulos, H. M. Primary versus secondary Sj\u00f6gren syndrome: is it time to reconsider these terms? J. Rheumatol. 46, 665\u2013666 (2019).","journal-title":"J. Rheumatol."},{"key":"1057_CR12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/acr.21591","volume":"64","author":"S Shiboski","year":"2012","unstructured":"Shiboski, S. et al. American College of Rheumatology classification criteria for Sj\u00f6gren\u2019s syndrome: a data-driven, expert consensus approach in the SICCA cohort. Arthritis Care Res. 64, 475\u2013487 (2012).","journal-title":"Arthritis Care Res."},{"key":"1057_CR13","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.55563\/clinexprheumatol\/3y0hqs","volume":"40","author":"C Baldini","year":"2022","unstructured":"Baldini, C., Bartoloni, E. & Bombardieri, M. Highlights of the 15th international symposium on Sj\u00f6gren\u2019s syndrome. Clin. Exp. Rheumatol. 40, 2201\u20132210 (2022).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1057_CR14","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/rheumatology\/kew023","volume":"55","author":"A Rasmussen","year":"2016","unstructured":"Rasmussen, A. et al. Previous diagnosis of Sj\u00f6gren\u2019s syndrome as rheumatoid arthritis or systemic lupus erythematosus. Rheumatology 55, 1195\u20131201 (2016).","journal-title":"Rheumatology"},{"key":"1057_CR15","first-page":"802","volume":"2003","author":"F Calvo","year":"2003","unstructured":"Calvo, F., Karras, B. T., Phillips, R., Kimball, A. M. & Wolf, F. Diagnoses, syndromes, and diseases: a knowledge representation problem. AMIA Annu. Symp. Proc. 2003, 802 (2003).","journal-title":"AMIA Annu. Symp. Proc."},{"key":"1057_CR16","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/art.41676","volume":"73","author":"AN Baer","year":"2021","unstructured":"Baer, A. N. & Hammitt, K. M. Sj\u00f6gren\u2019s disease, not syndrome. Arthritis Rheumatol. 73, 1347\u20131348 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"1057_CR17","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1136\/ard.46.4.286","volume":"46","author":"J Coll","year":"1987","unstructured":"Coll, J. et al. Prevalence of Sj\u00f6gren\u2019s syndrome in autoimmune diseases. Ann. Rheum. Dis. 46, 286\u2013289 (1987).","journal-title":"Ann. Rheum. Dis."},{"key":"1057_CR18","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1056\/NEJM197910043011405","volume":"301","author":"HM Moutsopoulos","year":"1979","unstructured":"Moutsopoulos, H. M., Mann, D. L., Johnson, A. H. & Chused, T. M. Genetic differences between primary and secondary sicca syndrome. N. Engl. J. Med. 301, 761\u2013763 (1979).","journal-title":"N. Engl. J. Med."},{"key":"1057_CR19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.7326\/0003-4819-92-2-212","volume":"92","author":"HM Moutsopoulos","year":"1980","unstructured":"Moutsopoulos, H. M. et al. Sj\u00f6gren\u2019s syndrome (Sicca syndrome): current issues. Ann. Intern. Med. 92, 212\u2013226 (1980).","journal-title":"Ann. Intern. Med."},{"key":"1057_CR20","doi-asserted-by":"publisher","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","volume":"89","author":"SS Kassan","year":"1978","unstructured":"Kassan, S. S. et al. Increased risk of lymphoma in sicca syndrome. Ann. Intern. Med. 89, 888\u2013892 (1978).","journal-title":"Ann. Intern. Med."},{"key":"1057_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002234","volume":"8","author":"N Hassold","year":"2022","unstructured":"Hassold, N., Seror, R., Mariette, X. & Nocturne, G. Characteristics of Sj\u00f6gren\u2019s syndrome associated with rheumatoid arthritis. RMD Open 8, e002234 (2022).","journal-title":"RMD Open"},{"key":"1057_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1023\/A:1018472213872","volume":"8","author":"M Kauppi","year":"1997","unstructured":"Kauppi, M., Pukkala, E. & Isom\u00e4ki, H. Elevated incidence of hematologic malignancies in patients with Sj\u00f6gren\u2019s syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control 8, 201\u2013204 (1997).","journal-title":"Cancer Causes Control"},{"key":"1057_CR23","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/rheumatology\/kes374","volume":"52","author":"J He","year":"2013","unstructured":"He, J. et al. Characteristics of Sjogren\u2019s syndrome in rheumatoid arthritis. Rheumatology 52, 1084\u20131089 (2013).","journal-title":"Rheumatology"},{"key":"1057_CR24","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1111\/j.1741-2358.2010.00420.x","volume":"29","author":"A-K Johansson","year":"2012","unstructured":"Johansson, A.-K. et al. Self-reported dry mouth in Swedish population samples aged 50, 65 and 75 years. Gerodontology 29, e107\u2013e115 (2012).","journal-title":"Gerodontology"},{"key":"1057_CR25","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0002-9394(03)00218-6","volume":"136","author":"DA Schaumberg","year":"2003","unstructured":"Schaumberg, D. A., Sullivan, D. A., Buring, J. E. & Dana, M. R. Prevalence of dry eye syndrome among US women. Am. J. Ophthalmol. 136, 318\u2013326 (2003).","journal-title":"Am. J. Ophthalmol."},{"key":"1057_CR26","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","volume":"15","author":"F Stapleton","year":"2017","unstructured":"Stapleton, F. et al. TFOS DEWS II epidemiology report. Ocul. Surf. 15, 334\u2013365 (2017).","journal-title":"Ocul. Surf."},{"key":"1057_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1136\/ard.55.2.116","volume":"55","author":"C Vitali","year":"1996","unstructured":"Vitali, C. et al. Assessment of the European classification criteria for Sj\u00f6gren\u2019s syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sj\u00f6gren\u2019s Syndrome. Ann. Rheum. Dis. 55, 116\u2013121 (1996).","journal-title":"Ann. Rheum. Dis."},{"key":"1057_CR28","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/art.1780360309","volume":"36","author":"C Vitali","year":"1993","unstructured":"Vitali, C. et al. Preliminary criteria for the classification of Sj\u00f6gren\u2019s syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 36, 340\u2013347 (1993).","journal-title":"Arthritis Rheum."},{"key":"1057_CR29","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali, C. et al. Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 61, 554\u2013558 (2002).","journal-title":"Ann. Rheum. Dis."},{"key":"1057_CR30","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1136\/annrheumdis-2016-210758","volume":"76","author":"H Tsuboi","year":"2017","unstructured":"Tsuboi, H. et al. Comparison of performance of the 2016 ACR-EULAR classification criteria for primary Sj\u00f6gren\u2019s syndrome with other sets of criteria in Japanese patients. Ann. Rheum. Dis. 76, 1980\u20131985 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"1057_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s13075-017-1475-x","volume":"19","author":"M Le Goff","year":"2017","unstructured":"Le Goff, M. et al. Comparison of 2002 AECG and 2016 ACR\/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sj\u00f6gren\u2019s syndrome. Arthritis Res. Ther. 19, 269 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"1057_CR32","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1136\/annrheumdis-2016-209952","volume":"76","author":"P Brito-Zer\u00f3n","year":"2017","unstructured":"Brito-Zer\u00f3n, P. et al. Influence of geolocation and ethnicity on the phenotypic expression of primary Sj\u00f6gren\u2019s syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sj\u00f6gren Project Consortium. Ann. Rheum. Dis. 76, 1042\u20131050 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"1057_CR33","doi-asserted-by":"publisher","first-page":"166","DOI":"10.55563\/clinexprheumatol\/egnd1i","volume":"39","author":"S Retamozo","year":"2021","unstructured":"Retamozo, S. et al. Influence of the age at diagnosis in the disease expression of primary Sj\u00f6gren syndrome. Analysis of 12,753 patients from the Sj\u00f6gren Big Data Consortium. Clin. Exp. Rheumatol. 39, 166\u2013174 (2021).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1057_CR34","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1093\/rheumatology\/kez578","volume":"59","author":"P Brito-Zer\u00f3n","year":"2020","unstructured":"Brito-Zer\u00f3n, P. et al. Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sj\u00f6gren\u2019s syndrome. Rheumatology 59, 2350\u20132359 (2020).","journal-title":"Rheumatology"},{"key":"1057_CR35","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1183\/16000617.0011-2016","volume":"25","author":"T Flament","year":"2016","unstructured":"Flament, T. et al. Pulmonary manifestations of Sj\u00f6gren\u2019s syndrome. Eur. Respir. Rev. 25, 110\u2013123 (2016).","journal-title":"Eur. Respir. Rev."},{"key":"1057_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13293-017-0137-7","volume":"8","author":"JI Ram\u00edrez Sep\u00falveda","year":"2017","unstructured":"Ram\u00edrez Sep\u00falveda, J. I., Kvarnstr\u00f6m, M., Brauner, S., Baldini, C. & Wahren-Herlenius, M. Difference in clinical presentation between women and men in incident primary Sj\u00f6gren\u2019s syndrome. Biol. Sex. Differ. 8, 16 (2017).","journal-title":"Biol. Sex. Differ."},{"key":"1057_CR37","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/rheumatology\/keab367","volume":"61","author":"L Wei","year":"2022","unstructured":"Wei, L. et al. Patients with early-onset primary Sj\u00f6gren\u2019s syndrome have distinctive clinical manifestations and circulating lymphocyte profiles. Rheumatology 61, 597\u2013605 (2022).","journal-title":"Rheumatology"},{"key":"1057_CR38","doi-asserted-by":"publisher","first-page":"594096","DOI":"10.3389\/fimmu.2020.594096","volume":"11","author":"AV Goules","year":"2020","unstructured":"Goules, A. V. et al. Primary Sj\u00f6gren\u2019s syndrome of early and late onset: distinct clinical phenotypes and lymphoma development. Front. Immunol. 11, 594096 (2020).","journal-title":"Front. Immunol."},{"key":"1057_CR39","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002955","volume":"9","author":"M Beydon","year":"2023","unstructured":"Beydon, M. et al. Impact of patient ancestry on heterogeneity of Sj\u00f6gren\u2019s disease. RMD Open 9, e002955 (2023).","journal-title":"RMD Open"},{"key":"1057_CR40","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/ard.56.9.521","volume":"56","author":"D Dafni","year":"1997","unstructured":"Dafni, D., Ag, T., P, S., Fn, S. & Hm, M. Prevalence of Sj\u00f6gren\u2019s syndrome in a closed rural community. Ann. Rheum. Dis. 56, 521\u2013525 (1997).","journal-title":"Ann. Rheum. Dis."},{"key":"1057_CR41","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/rheumatology\/38.2.164","volume":"38","author":"M Tomsic","year":"1999","unstructured":"Tomsic, M., Logar, D., Grmek, M., Perkovic, T. & Kveder, T. Prevalence of Sj\u00f6gren\u2019s syndrome in Slovenia. Rheumatology 38, 164\u2013170 (1999).","journal-title":"Rheumatology"},{"key":"1057_CR42","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1136\/ard.2004.031021","volume":"64","author":"PI Trontzas","year":"2005","unstructured":"Trontzas, P. I. & Andrianakos, A. A. Sjogren\u2019s syndrome: a population based study of prevalence in Greece. The ESORDIG study. Ann. Rheum. Dis. 64, 1240\u20131241 (2005).","journal-title":"Ann. Rheum. Dis."},{"key":"1057_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/rheumatology\/kei107","volume":"45","author":"Y Alamanos","year":"2006","unstructured":"Alamanos, Y. et al. Epidemiology of primary Sj\u00f6gren\u2019s syndrome in north-west Greece, 1982\u20132003. Rheumatology 45, 187\u2013191 (2006).","journal-title":"Rheumatology"},{"key":"1057_CR44","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/acr.22115","volume":"66","author":"C Maldini","year":"2014","unstructured":"Maldini, C. et al. Epidemiology of primary Sj\u00f6gren\u2019s syndrome in a French multiracial\/multiethnic area. Arthritis Care Res. 66, 454\u2013463 (2014).","journal-title":"Arthritis Care Res."},{"key":"1057_CR45","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00296-008-0809-z","volume":"29","author":"Y-J Xiang","year":"2009","unstructured":"Xiang, Y.-J. & Dai, S.-M. Prevalence of rheumatic diseases and disability in China. Rheumatol. Int. 29, 481\u2013490 (2009).","journal-title":"Rheumatol. Int."},{"key":"1057_CR46","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.semarthrit.2013.06.001","volume":"43","author":"L-C See","year":"2013","unstructured":"See, L.-C., Kuo, C.-F., Chou, I.-J., Chiou, M.-J. & Yu, K.-H. Sex- and age-specific incidence of autoimmune rheumatic diseases in the Chinese population: a Taiwan population-based study. Semin. Arthritis Rheum. 43, 381\u2013386 (2013).","journal-title":"Semin. Arthritis Rheum."},{"key":"1057_CR47","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1136\/annrheumdis-2021-eular.78","volume":"80","author":"R Seror","year":"2021","unstructured":"Seror, R. et al. Pos0024 estimated prevalence, incidence and healthcare costs of Sj\u00f6gren\u2019s syndrome in France: a national claims-based study. Ann. Rheum. Dis. 80, 214\u2013215 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"1057_CR48","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1002\/acr.23173","volume":"69","author":"G Maciel","year":"2017","unstructured":"Maciel, G., Crowson, C. S., Matteson, E. L. & Cornec, D. Prevalence of primary Sj\u00f6gren\u2019s syndrome in a US population-based cohort. Arthritis Care Res. 69, 1612\u20131616 (2017).","journal-title":"Arthritis Care Res."},{"key":"1057_CR49","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/acr.23223","volume":"70","author":"G Nocturne","year":"2018","unstructured":"Nocturne, G. et al. Primary Sj\u00f6gren\u2019s syndrome prevalence: What if Sj\u00f6gren was right after all? Comment on the article by Maciel et al. Arthritis Care Res. 70, 951\u2013953 (2018).","journal-title":"Arthritis Care Res."},{"key":"1057_CR50","first-page":"24","volume":"53","author":"V Valim","year":"2013","unstructured":"Valim, V. et al. Primary Sj\u00f6gren\u2019s syndrome prevalence in a major metropolitan area in Brazil. Rev. Bras. Reumatol. 53, 24\u201334 (2013).","journal-title":"Rev. Bras. Reumatol."},{"key":"1057_CR51","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","volume":"74","author":"B Qin","year":"2015","unstructured":"Qin, B. et al. Epidemiology of primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis. Ann. Rheum. Dis. 74, 1983\u20131989 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"1057_CR52","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0025-6196(11)62408-7","volume":"76","author":"SR Pillemer","year":"2001","unstructured":"Pillemer, S. R. et al. Incidence of physician-diagnosed primary Sj\u00f6gren syndrome in residents of Olmsted County, Minnesota. Mayo Clin. Proc. 76, 593\u2013599 (2001).","journal-title":"Mayo Clin. Proc."},{"key":"1057_CR53","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/acr.23707","volume":"71","author":"PM Izmirly","year":"2019","unstructured":"Izmirly, P. M. et al. The incidence and prevalence of adult primary Sj\u00f6gren\u2019s syndrome in New York County. Arthritis Care Res. 71, 949\u2013960 (2019).","journal-title":"Arthritis Care Res."},{"key":"1057_CR54","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3899\/jrheum.100883","volume":"38","author":"M-Y Weng","year":"2011","unstructured":"Weng, M.-Y., Huang, Y.-T., Liu, M.-F. & Lu, T.-H. Incidence and mortality of treated primary Sjogren\u2019s syndrome in Taiwan: a population-based study. J. Rheumatol. 38, 706\u2013708 (2011).","journal-title":"J. Rheumatol."},{"key":"1057_CR55","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/acr.21820","volume":"65","author":"K-H Yu","year":"2013","unstructured":"Yu, K.-H., See, L.-C., Kuo, C.-F., Chou, I.-J. & Chou, M.-J. Prevalence and incidence in patients with autoimmune rheumatic diseases: a nationwide population-based study in Taiwan. Arthritis Care Res. 65, 244\u2013250 (2013).","journal-title":"Arthritis Care Res."},{"key":"1057_CR56","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10067-022-06474-8","volume":"42","author":"L Jin","year":"2023","unstructured":"Jin, L., Dai, M., Li, C., Wang, J. & Wu, B. Risk factors for primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis. Clin. Rheumatol. 42, 327\u2013338 (2023).","journal-title":"Clin. Rheumatol."},{"key":"1057_CR57","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/ard.2008.102962","volume":"69","author":"EW Karlson","year":"2010","unstructured":"Karlson, E. W. et al. Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann. Rheum. Dis. 69, 54\u201360 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"1057_CR58","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001402","volume":"6","author":"J Mofors","year":"2020","unstructured":"Mofors, J. et al. Cigarette smoking patterns preceding primary Sj\u00f6gren\u2019s syndrome. RMD Open\u00a06, e001402 (2020).","journal-title":"RMD Open"},{"key":"1057_CR59","doi-asserted-by":"publisher","first-page":"9060842","DOI":"10.1155\/2019\/9060842","volume":"2019","author":"H Ben-Eli","year":"2019","unstructured":"Ben-Eli, H. et al. Shared medical and environmental risk factors in dry eye syndrome, Sjogren\u2019s syndrome, and B-cell non-Hodgkin lymphoma: a case-control study. J. Immunol. Res. 2019, 9060842 (2019).","journal-title":"J. Immunol. Res."},{"key":"1057_CR60","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13075-017-1255-7","volume":"19","author":"P Olsson","year":"2017","unstructured":"Olsson, P., Turesson, C., Mandl, T., Jacobsson, L. & Theander, E. Cigarette smoking and the risk of primary Sj\u00f6gren\u2019s syndrome: a nested case control study. Arthritis Res. Ther. 19, 50 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"1057_CR61","first-page":"378","volume":"25","author":"R Priori","year":"2007","unstructured":"Priori, R. et al. Risk factors for Sj\u00f6gren\u2019s syndrome: a case-control study. Clin. Exp. Rheumatol. 25, 378\u2013384 (2007).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1057_CR62","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1093\/rheumatology\/keab101","volume":"60","author":"C Salliot","year":"2021","unstructured":"Salliot, C. et al. Female hormonal exposures and risk of rheumatoid arthritis in the French E3N-EPIC cohort study. Rheumatology 60, 4790\u20134800 (2021).","journal-title":"Rheumatology"},{"key":"1057_CR63","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/acr.24014","volume":"72","author":"SS McCoy","year":"2020","unstructured":"McCoy, S. S., Sampene, E. & Baer, A. N. Association of Sj\u00f6gren\u2019s syndrome with reduced lifetime sex hormone exposure: a case-control study. Arthritis Care Res. 72, 1315\u20131322 (2020).","journal-title":"Arthritis Care Res."},{"key":"1057_CR64","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/rheumatology\/keq158","volume":"49","author":"D Karaiskos","year":"2010","unstructured":"Karaiskos, D. et al. Psychopathological and personality features in primary Sjogren\u2019s syndrome \u2014 associations with autoantibodies to neuropeptides. Rheumatology 49, 1762\u20131769 (2010).","journal-title":"Rheumatology"},{"key":"1057_CR65","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/NDT.S287798","volume":"17","author":"F Meng","year":"2021","unstructured":"Meng, F., Ren, S., Meng, Y., Tao, N. & Zhang, J. Association between stressful life events and female primary Sjogren\u2019s syndrome and their role in disease activity: a retrospective case-control study in China. Neuropsychiatr. Dis. Treat. 17, 213\u2013220 (2021).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"1057_CR66","first-page":"216","volume":"38","author":"A Machowicz","year":"2020","unstructured":"Machowicz, A. et al. Mediterranean diet and risk of Sj\u00f6gren\u2019s syndrome. Clin. Exp. Rheumatol. 38, 216\u2013221 (2020).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1057_CR67","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/rheumatology\/kew291","volume":"55","author":"AG Singh","year":"2016","unstructured":"Singh, A. G., Singh, S. & Matteson, E. L. Rate, risk factors and causes of mortality in patients with Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis of cohort studies. Rheumatology 55, 450\u2013460 (2016).","journal-title":"Rheumatology"},{"key":"1057_CR68","first-page":"958","volume":"30","author":"E Thomas","year":"2003","unstructured":"Thomas, E., Symmons, D. P. M., Brewster, D. H., Black, R. J. & Macfarlane, G. J. National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study. J. Rheumatol. 30, 958\u2013965 (2003).","journal-title":"J. Rheumatol."},{"key":"1057_CR69","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/annrheumdis-2014-206418","volume":"75","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n, P. et al. Systemic activity and mortality in primary Sj\u00f6gren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients. Ann. Rheum. Dis. 75, 348\u2013355 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"1057_CR70","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.semarthrit.2017.03.004","volume":"47","author":"HJ Kim","year":"2017","unstructured":"Kim, H. J. et al. Incidence, mortality, and causes of death in physician-diagnosed primary Sj\u00f6gren\u2019s syndrome in Korea: a nationwide, population-based study. Semin. Arthritis Rheum. 47, 222\u2013227 (2017).","journal-title":"Semin. Arthritis Rheum."},{"key":"1057_CR71","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10067-019-04744-6","volume":"39","author":"V Yazisiz","year":"2020","unstructured":"Yazisiz, V. et al. Survival analysis of patients with Sj\u00f6gren\u2019s syndrome in Turkey: a tertiary hospital-based study. Clin. Rheumatol. 39, 233\u2013241 (2020).","journal-title":"Clin. Rheumatol."},{"key":"1057_CR72","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.mayocp.2017.01.020","volume":"92","author":"G Maciel","year":"2017","unstructured":"Maciel, G., Crowson, C. S., Matteson, E. L. & Cornec, D. Incidence and mortality of physician-diagnosed primary Sj\u00f6gren\u2019s syndrome: time trends over a 40-year period in a population-based cohort in the United States. Mayo Clin. Proc. 92, 734\u2013743 (2017).","journal-title":"Mayo Clin. Proc."},{"key":"1057_CR73","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/art.20176","volume":"50","author":"E Theander","year":"2004","unstructured":"Theander, E., Manthorpe, R. & Jacobsson, L. T. H. Mortality and causes of death in primary Sj\u00f6gren\u2019s syndrome: a prospective cohort study. Arthritis Rheum. 50, 1262\u20131269 (2004).","journal-title":"Arthritis Rheum."},{"key":"1057_CR74","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/rheumatology\/keh407","volume":"44","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals, M. et al. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren\u2019s syndrome. Rheumatology 44, 89\u201394 (2005).","journal-title":"Rheumatology"},{"key":"1057_CR75","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/art.10221","volume":"46","author":"JPA Ioannidis","year":"2002","unstructured":"Ioannidis, J. P. A., Vassiliou, V. A. & Moutsopoulos, H. M. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheum. 46, 741\u2013747 (2002).","journal-title":"Arthritis Rheum."},{"key":"1057_CR76","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","volume":"29","author":"FN Skopouli","year":"2000","unstructured":"Skopouli, F. N., Dafni, U., Ioannidis, J. P. & Moutsopoulos, H. M. Clinical evolution, and morbidity and mortality of primary Sj\u00f6gren\u2019s syndrome. Semin. Arthritis Rheum. 29, 296\u2013304 (2000).","journal-title":"Semin. Arthritis Rheum."},{"key":"1057_CR77","doi-asserted-by":"publisher","first-page":"647507","DOI":"10.1155\/2014\/647507","volume":"2014","author":"IF Horvath","year":"2014","unstructured":"Horvath, I. F., Szanto, A., Papp, G. & Zeher, M. Clinical course, prognosis, and cause of death in primary Sj\u00f6gren\u2019s syndrome. J. Immunol. Res. 2014, 647507 (2014).","journal-title":"J. Immunol. Res."},{"key":"1057_CR78","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/rheumatology\/kes311","volume":"52","author":"O Palm","year":"2013","unstructured":"Palm, O. et al. Clinical pulmonary involvement in primary Sjogren\u2019s syndrome: prevalence, quality of life and mortality \u2014 a retrospective study based on registry data. Rheumatology 52, 173\u2013179 (2013).","journal-title":"Rheumatology"},{"key":"1057_CR79","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-017-0464-5","volume":"10","author":"P Brito-Zer\u00f3n","year":"2017","unstructured":"Brito-Zer\u00f3n, P. et al. Characterization and risk estimate of cancer in patients with primary Sj\u00f6gren syndrome. J. Hematol. Oncol. 10, 90 (2017).","journal-title":"J. Hematol. Oncol."},{"key":"1057_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0b013e31824125e4","volume":"91","author":"M Voulgarelis","year":"2012","unstructured":"Voulgarelis, M. et al. Prognosis and outcome of non-Hodgkin lymphoma in primary Sj\u00f6gren syndrome. Medicine 91, 1\u20139 (2012).","journal-title":"Medicine"},{"key":"1057_CR81","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1136\/ard.2005.041186","volume":"65","author":"E Theander","year":"2006","unstructured":"Theander, E. et al. Lymphoma and other malignancies in primary Sj\u00f6gren\u2019s syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann. Rheum. Dis. 65, 796\u2013803 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"1057_CR82","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/acr.21887","volume":"65","author":"SJ Johnsen","year":"2013","unstructured":"Johnsen, S. J. et al. Risk of non-Hodgkin\u2019s lymphoma in primary Sj\u00f6gren\u2019s syndrome: a population-based study. Arthritis Care Res. 65, 816\u2013821 (2013).","journal-title":"Arthritis Care Res."},{"key":"1057_CR83","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1093\/annonc\/mdu365","volume":"25","author":"M Fallah","year":"2014","unstructured":"Fallah, M. et al. Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study. Ann. Oncol. 25, 2025\u20132030 (2014).","journal-title":"Ann. Oncol."},{"key":"1057_CR84","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/art.39518","volume":"68","author":"G Nocturne","year":"2016","unstructured":"Nocturne, G. et al. Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sj\u00f6gren\u2019s syndrome: characteristics and predictors of lymphoma in primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 68, 977\u2013985 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"1057_CR85","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3899\/jrheum.191027","volume":"47","author":"L-H Wang","year":"2020","unstructured":"Wang, L.-H., Wang, W.-M., Lin, C.-Y., Lin, S.-H. & Shieh, C.-C. Bidirectional relationship between primary Sj\u00f6gren syndrome and non-Hodgkin lymphoma: a nationwide Taiwanese population-based study. J. Rheumatol. 47, 1374\u20131378 (2020).","journal-title":"J. Rheumatol."},{"key":"1057_CR86","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1093\/rheumatology\/kez052","volume":"60","author":"G Nocturne","year":"2021","unstructured":"Nocturne, G., Pontarini, E., Bombardieri, M. & Mariette, X. Lymphomas complicating primary Sj\u00f6gren\u2019s syndrome: from autoimmunity to lymphoma. Rheumatology 60, 3513\u20133521 (2021).","journal-title":"Rheumatology"},{"key":"1057_CR87","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1172\/JCI3234","volume":"102","author":"DI Stott","year":"1998","unstructured":"Stott, D. I., Hiepe, F., Hummel, M., Steinhauser, G. & Berek, C. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sj\u00f6gren\u2019s syndrome. J. Clin. Invest. 102, 938\u2013946 (1998).","journal-title":"J. Clin. Invest."},{"key":"1057_CR88","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1084\/jem.20050068","volume":"201","author":"RJ Bende","year":"2005","unstructured":"Bende, R. J. et al. Among B cell non-Hodgkin\u2019s lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity. J. Exp. Med. 201, 1229\u20131241 (2005).","journal-title":"J. Exp. Med."},{"key":"1057_CR89","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/rheumatology\/kep404","volume":"49","author":"W Zhang","year":"2010","unstructured":"Zhang, W. et al. Incidence of malignancy in primary Sjogren\u2019s syndrome in a Chinese cohort. Rheumatology 49, 571\u2013577 (2010).","journal-title":"Rheumatology"},{"key":"1057_CR90","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.semarthrit.2011.04.006","volume":"41","author":"R Solans-Laqu\u00e9","year":"2011","unstructured":"Solans-Laqu\u00e9, R. et al. Risk, predictors, and clinical characteristics of lymphoma development in primary Sj\u00f6gren\u2019s syndrome. Semin. Arthritis Rheum. 41, 415\u2013423 (2011).","journal-title":"Semin. Arthritis Rheum."},{"key":"1057_CR91","doi-asserted-by":"publisher","first-page":"102648","DOI":"10.1016\/j.jaut.2021.102648","volume":"121","author":"L Chatzis","year":"2021","unstructured":"Chatzis, L. et al. A biomarker for lymphoma development in Sjogren\u2019s syndrome: salivary gland focus score. J. Autoimmun. 121, 102648 (2021).","journal-title":"J. Autoimmun."},{"key":"1057_CR92","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1136\/annrheumdis-2013-204634","volume":"73","author":"AP Risselada","year":"2014","unstructured":"Risselada, A. P. et al. The prognostic value of routinely performed minor salivary gland assessments in primary Sj\u00f6gren\u2019s syndrome. Ann. Rheum. Dis. 73, 1537\u20131540 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"1057_CR93","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jaut.2013.10.002","volume":"51","author":"L Quartuccio","year":"2014","unstructured":"Quartuccio, L. et al. Biomarkers of lymphoma in Sj\u00f6gren\u2019s syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. J. Autoimmun. 51, 75\u201380 (2014).","journal-title":"J. Autoimmun."},{"key":"1057_CR94","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.ajo.2005.05.025","volume":"140","author":"M Fujita","year":"2005","unstructured":"Fujita, M. et al. Correlation between dry eye and rheumatoid arthritis activity. Am. J. Ophthalmol. 140, 808\u2013813 (2005).","journal-title":"Am. J. Ophthalmol."},{"key":"1057_CR95","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1590\/S0104-42302011000300015","volume":"57","author":"DC Antero","year":"2011","unstructured":"Antero, D. C., Parra, A. G. M., Miyazaki, F. H., Gehlen, M. & Skare, T. L. Secondary Sj\u00f6gren\u2019s syndrome and disease activity of rheumatoid arthritis. Rev. Assoc. Med. Bras. 57, 319\u2013322 (2011).","journal-title":"Rev. Assoc. Med. Bras."},{"key":"1057_CR96","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1007\/s10067-020-05004-8","volume":"39","author":"LR Harrold","year":"2020","unstructured":"Harrold, L. R. et al. Prevalence of Sj\u00f6gren\u2019s syndrome associated with rheumatoid arthritis in the USA: an observational study from the Corrona registry. Clin. Rheumatol. 39, 1899\u20131905 (2020).","journal-title":"Clin. Rheumatol."},{"key":"1057_CR97","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/rheumatology\/keu400","volume":"54","author":"LE Brown","year":"2015","unstructured":"Brown, L. E. et al. Clinical characteristics of RA patients with secondary SS and association with joint damage. Rheumatology 54, 816\u2013820 (2015).","journal-title":"Rheumatology"},{"key":"1057_CR98","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1756-185X.2012.01717.x","volume":"15","author":"H-J Haga","year":"2012","unstructured":"Haga, H.-J., Naderi, Y., Moreno, A. M. & Peen, E. A study of the prevalence of sicca symptoms and secondary Sj\u00f6gren\u2019s syndrome in patients with rheumatoid arthritis, and its association to disease activity and treatment profile. Int. J. Rheum. Dis. 15, 284\u2013288 (2012).","journal-title":"Int. J. Rheum. Dis."},{"key":"1057_CR99","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1136\/ard.2003.019794","volume":"64","author":"J-E Gottenberg","year":"2005","unstructured":"Gottenberg, J.-E. et al. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sj\u00f6gren\u2019s syndrome. Ann. Rheum. Dis. 64, 114\u2013117 (2005).","journal-title":"Ann. Rheum. Dis."},{"key":"1057_CR100","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1186\/ar2420","volume":"10","author":"F Atzeni","year":"2008","unstructured":"Atzeni, F. et al. Anti-cyclic citrullinated peptide antibodies in primary Sj\u00f6gren syndrome may be associated with non-erosive synovitis. Arthritis Res. Ther. 10, R51 (2008).","journal-title":"Arthritis Res. Ther."},{"key":"1057_CR101","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1136\/ard.59.3.230","volume":"59","author":"JE McDonagh","year":"2000","unstructured":"McDonagh, J. E. & Isenberg, D. A. Development of additional autoimmune diseases in a population of patients with systemic lupus erythematosus. Ann. Rheum. Dis. 59, 230\u2013232 (2000).","journal-title":"Ann. Rheum. Dis."},{"key":"1057_CR102","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/art.20093","volume":"50","author":"MN Manoussakis","year":"2004","unstructured":"Manoussakis, M. N. et al. Sj\u00f6gren\u2019s syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheum. 50, 882\u2013891 (2004).","journal-title":"Arthritis Rheum."},{"key":"1057_CR103","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10067-007-0720-0","volume":"27","author":"HF Pan","year":"2008","unstructured":"Pan, H. F. et al. Clinical and laboratory profiles of systemic lupus erythematosus associated with Sj\u00f6gren syndrome in China: a study of 542 patients. Clin. Rheumatol. 27, 339\u2013343 (2008).","journal-title":"Clin. Rheumatol."},{"key":"1057_CR104","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3899\/jrheum.090804","volume":"37","author":"AN Baer","year":"2010","unstructured":"Baer, A. N., Maynard, J. W., Shaikh, F., Magder, L. S. & Petri, M. Secondary Sjogren\u2019s syndrome in systemic lupus erythematosus defines a distinct disease subset. J. Rheumatol. 37, 1143\u20131149 (2010).","journal-title":"J. Rheumatol."},{"key":"1057_CR105","first-page":"298506","volume":"2015","author":"R Aggarwal","year":"2015","unstructured":"Aggarwal, R., Anaya, J.-M., Koelsch, K. A., Kurien, B. T. & Scofield, R. H. Association between secondary and primary Sj\u00f6gren\u2019s syndrome in a large collection of lupus families. Autoimmune Dis. 2015, 298506 (2015).","journal-title":"Autoimmune Dis."},{"key":"1057_CR106","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.humimm.2006.06.006","volume":"67","author":"A Szanto","year":"2006","unstructured":"Szanto, A. et al. Clinical, serologic, and genetic profiles of patients with associated Sj\u00f6gren\u2019s syndrome and systemic lupus erythematosus. Hum. Immunol. 67, 924\u2013930 (2006).","journal-title":"Hum. Immunol."},{"key":"1057_CR107","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1191\/096120398678920046","volume":"7","author":"JC Nossent","year":"1998","unstructured":"Nossent, J. C. & Swaak, A. J. Systemic lupus erythematosus VII: frequency and impact of secondary Sj\u00f8gren\u2019s syndrome. Lupus 7, 231\u2013234 (1998).","journal-title":"Lupus"},{"key":"1057_CR108","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/0961203309348235","volume":"19","author":"D Xu","year":"2010","unstructured":"Xu, D. et al. Sj\u00f6gren\u2019s syndrome-onset lupus patients have distinctive clinical manifestations and benign prognosis: a case\u2013control study. Lupus 19, 197\u2013200 (2010).","journal-title":"Lupus"},{"key":"1057_CR109","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/RHU.0b013e31823ecbdf","volume":"18","author":"Q Yao","year":"2012","unstructured":"Yao, Q., Altman, R. D. & Wang, X. Systemic lupus erythematosus with Sj\u00f6gren syndrome compared to systemic lupus erythematosus alone: a meta-analysis. J. Clin. Rheumatol. 18, 28\u201332 (2012).","journal-title":"J. Clin. Rheumatol."},{"key":"1057_CR110","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.semarthrit.2005.12.004","volume":"35","author":"M Ramos-Casals","year":"2006","unstructured":"Ramos-Casals, M. et al. Atypical autoantibodies in patients with primary Sj\u00f6gren syndrome: clinical characteristics and follow-up of 82 cases. Semin. Arthritis Rheumatism 35, 312\u2013321 (2006).","journal-title":"Semin. Arthritis Rheumatism"},{"key":"1057_CR111","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1136\/annrheumdis-2019-216222","volume":"80","author":"F Assan","year":"2021","unstructured":"Assan, F., Seror, R., Mariette, X. & Nocturne, G. New 2019 SLE EULAR\/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS. Ann. Rheum. Dis. 80, e122\u2013e122 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"1057_CR112","first-page":"322","volume":"117","author":"M Hadj Said","year":"2016","unstructured":"Hadj Said, M., Foletti, J. M., Graillon, N., Guyot, L. & Chossegros, C. Orofacial manifestations of scleroderma. A literature review. Rev. Stomatol. Chir. Maxillofac. Chir. Orale 117, 322\u2013326 (2016).","journal-title":"Rev. Stomatol. Chir. Maxillofac. Chir. Orale"},{"key":"1057_CR113","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1002\/art.21922","volume":"54","author":"J Avouac","year":"2006","unstructured":"Avouac, J. et al. Systemic sclerosis-associated Sj\u00f6gren\u2019s syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum. 54, 2243\u20132249 (2006).","journal-title":"Arthritis Rheum."},{"key":"1057_CR114","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1756-185X.2012.01810.x","volume":"16","author":"S Kobak","year":"2013","unstructured":"Kobak, S., Oksel, F., Aksu, K. & Kabasakal, Y. The frequency of sicca symptoms and Sj\u00f6gren\u2019s syndrome in patients with systemic sclerosis. Int. J. Rheum. Dis. 16, 88\u201392 (2013).","journal-title":"Int. J. Rheum. Dis."},{"key":"1057_CR115","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3899\/jrheum.090815","volume":"37","author":"J Avouac","year":"2010","unstructured":"Avouac, J. et al. Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patients. J. Rheumatol. 37, 608\u2013614 (2010).","journal-title":"J. Rheumatol."},{"key":"1057_CR116","first-page":"272","volume":"31","author":"C Baldini","year":"2013","unstructured":"Baldini, C. et al. Overlap of ACA-positive systemic sclerosis and Sj\u00f6gren\u2019s syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma. Clin. Exp. Rheumatol. 31, 272\u2013280 (2013).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1057_CR117","doi-asserted-by":"publisher","first-page":"102690","DOI":"10.1016\/j.autrev.2020.102690","volume":"19","author":"M Bautista-Vargas","year":"2020","unstructured":"Bautista-Vargas, M., Vivas, A. J. & Tob\u00f3n, G. J. Minor salivary gland biopsy: its role in the classification and prognosis of Sj\u00f6gren\u2019s syndrome. Autoimmun. Rev. 19, 102690 (2020).","journal-title":"Autoimmun. Rev."},{"key":"1057_CR118","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/acr.22859","volume":"68","author":"AN Baer","year":"2016","unstructured":"Baer, A. N., Medrano, L., McAdams-DeMarco, M. & Gniadek, T. J. Anti-centromere antibodies are associated with more severe exocrine glandular dysfunction in Sj\u00f6gren\u2019s syndrome: analysis of the Sj\u00f6gren\u2019s International Collaborative Clinical Alliance cohort. Arthritis Care Res. 68, 1554\u20131559 (2016).","journal-title":"Arthritis Care Res."},{"key":"1057_CR119","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/rheumatology\/kes350","volume":"52","author":"LK Mercer","year":"2013","unstructured":"Mercer, L. K. et al. Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population. Rheumatology 52, 91\u201398 (2013).","journal-title":"Rheumatology"},{"key":"1057_CR120","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1136\/annrheumdis-2012-202099","volume":"73","author":"S Bernatsky","year":"2014","unstructured":"Bernatsky, S. et al. Lymphoma risk in systemic lupus: effects of disease activity versus treatment. Ann. Rheum. Dis. 73, 138\u2013142 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"1057_CR121","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1097\/RHU.0000000000001708","volume":"28","author":"M Essouma","year":"2022","unstructured":"Essouma, M., Noubiap, J. J., Singwe-Ngandeu, M. & Hachulla, E. Epidemiology of Sj\u00f6gren syndrome in Africa: a scoping review. J. Clin. Rheumatol. 28, e240\u2013e244 (2022).","journal-title":"J. Clin. Rheumatol."},{"key":"1057_CR122","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/art.42238","volume":"74","author":"SS McCoy","year":"2022","unstructured":"McCoy, S. S. et al. Symptom-based cluster analysis categorizes Sj\u00f6gren\u2019s disease subtypes: an international cohort study highlighting disease severity and treatment discordance. Arthritis Rheumatol. 74, 1569\u20131579 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"1057_CR123","first-page":"305","volume":"82","author":"Y Nguyen","year":"2023","unstructured":"Nguyen, Y. et al. Determination of distinct phenotypes of primary Sj\u00f6gren\u2019s disease using cluster analysis based on clinical and biological manifestations: data from 458 patients from the Paris Saclay Sj\u00f6gren\u2019s Syndrome Cohort [POS0165]. Ann. Rheum. Dis. 82, 305\u2013306 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"1057_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23472-7","volume":"12","author":"P Soret","year":"2021","unstructured":"Soret, P. et al. A new molecular classification to drive precision treatment strategies in primary Sj\u00f6gren\u2019s syndrome. Nat. Commun. 12, 3523 (2021).","journal-title":"Nat. Commun."},{"key":"1057_CR125","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1016\/S2665-9913(19)30042-6","volume":"1","author":"JR Tarn","year":"2019","unstructured":"Tarn, J. R. et al. Symptom-based stratification of patients with primary Sj\u00f6gren\u2019s syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials. Lancet Rheumatol. 1, e85\u2013e94 (2019).","journal-title":"Lancet Rheumatol."},{"key":"1057_CR126","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1136\/annrheumdis-2021-222054","volume":"81","author":"R Seror","year":"2022","unstructured":"Seror, R. et al. Development and preliminary validation of the Sj\u00f6gren\u2019s Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sj\u00f6gren\u2019s syndrome. Ann. Rheum. Dis. 81, 979\u2013989 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"1057_CR127","doi-asserted-by":"publisher","first-page":"17","DOI":"10.55563\/clinexprheumatol\/u7knfy","volume":"39","author":"AV Goules","year":"2021","unstructured":"Goules, A. V., Exarchos, T. P., Fotiadis, D. I. & Tzioufas, A. The clinical and technical impact of the HarmonicSS project. Clin. Exp. Rheumatol. 39, 17\u201319 (2021).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1057_CR128","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2188\/jea.5.125","volume":"5","author":"K Wakai","year":"1995","unstructured":"Wakai, K. et al. Estimated prevalence of Sjogren\u2019s syndrome in Japan: findings from a nationwide epidemiological survey. J. Epidemiol. 5, 125\u2013129 (1995).","journal-title":"J. Epidemiol."},{"key":"1057_CR129","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1093\/rheumatology\/37.10.1069","volume":"37","author":"E Thomas","year":"1998","unstructured":"Thomas, E., Hay, E. M., Hajeer, A. & Silman, A. J. Sj\u00f6gren\u2019s syndrome: a community-based study of prevalence and impact. Br. J. Rheumatol. 37, 1069\u20131076 (1998).","journal-title":"Br. J. Rheumatol."},{"key":"1057_CR130","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/03009740310004676","volume":"33","author":"SJ Bowman","year":"2004","unstructured":"Bowman, S. J., Ibrahim, G. H., Holmes, G., Hamburger, J. & Ainsworth, J. R. Estimating the prevalence among Caucasian women of primary Sj\u00f6gren\u2019s syndrome in two general practices in Birmingham, UK. Scand. J. Rheumatol. 33, 39\u201343 (2004).","journal-title":"Scand. J. Rheumatol."},{"key":"1057_CR131","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/03009740600759704","volume":"35","author":"Y Kabasakal","year":"2006","unstructured":"Kabasakal, Y. et al. The prevalence of Sj\u00f6gren\u2019s syndrome in adult women. Scand. J. Rheumatol. 35, 379\u2013383 (2006).","journal-title":"Scand. J. Rheumatol."},{"key":"1057_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2007.05.002","volume":"29","author":"WW Eaton","year":"2007","unstructured":"Eaton, W. W., Rose, N. R., Kalaydjian, A., Pedersen, M. G. & Mortensen, P. B. Epidemiology of autoimmune diseases in Denmark. J. Autoimmun. 29, 1\u20139 (2007).","journal-title":"J. Autoimmun."},{"key":"1057_CR133","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/j.1742-1241.2008.01749.x","volume":"63","author":"M Birlik","year":"2009","unstructured":"Birlik, M. et al. Prevalence of primary Sjogren\u2019s syndrome in Turkey: a population-based epidemiological study. Int. J. Clin. Pract. 63, 954\u2013961 (2009).","journal-title":"Int. J. Clin. Pract."},{"key":"1057_CR134","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-11-98","volume":"11","author":"I Anagnostopoulos","year":"2010","unstructured":"Anagnostopoulos, I. et al. The prevalence of rheumatic diseases in central Greece: a population survey. BMC Musculoskelet. Disord. 11, 98 (2010).","journal-title":"BMC Musculoskelet. Disord."},{"key":"1057_CR135","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3109\/03009742.2010.536164","volume":"40","author":"L G\u00f8ransson","year":"2011","unstructured":"G\u00f8ransson, L. et al. The point prevalence of clinically relevant primary Sj\u00f6gren\u2019s syndrome in two Norwegian counties. Scand. J. Rheumatol. 40, 221\u2013224 (2011).","journal-title":"Scand. J. Rheumatol."},{"key":"1057_CR136","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032487","volume":"7","author":"C Sardu","year":"2012","unstructured":"Sardu, C. et al. Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity. PLoS ONE 7, e32487 (2012).","journal-title":"PLoS ONE"},{"key":"1057_CR137","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3109\/14397595.2013.843765","volume":"24","author":"H Tsuboi","year":"2014","unstructured":"Tsuboi, H. et al. Primary and secondary surveys on epidemiology of Sj\u00f6gren\u2019s syndrome in Japan. Mod. Rheumatol. 24, 464\u2013470 (2014).","journal-title":"Mod. Rheumatol."},{"key":"1057_CR138","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3109\/s10165-004-0338-x","volume":"14","author":"T Fujibayashi","year":"2004","unstructured":"Fujibayashi, T., Sugai, S., Miyasaka, N., Hayashi, Y. & Tsubota, K. Revised Japanese criteria for Sj\u00f6gren\u2019s syndrome (1999): availability and validity. Mod. Rheumatol. 14, 425\u2013434 (2004).","journal-title":"Mod. Rheumatol."},{"key":"1057_CR139","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.2105\/AJPH.56.8.1277","volume":"56","author":"IM Moriyama","year":"1966","unstructured":"Moriyama, I. M. The eighth revision of the International Classification of Diseases. Am. J. Public Health Nations Health 56, 1277\u20131280 (1966).","journal-title":"Am. J. Public Health Nations Health"},{"key":"1057_CR140","unstructured":"Br\u00e4mer, G. R. International statistical classification of diseases and related health problems. Tenth revision. World Health Stat. Q 41, 32\u201336 (1988)."},{"key":"1057_CR141","first-page":"19","volume":"61","author":"R Manthorpe","year":"1986","unstructured":"Manthorpe, R., Oxholm, P., Prause, J. U. & Schi\u00f8dt, M. The Copenhagen criteria for Sj\u00f6gren\u2019s syndrome. Scand. J. Rheumatol. Suppl. 61, 19\u201321 (1986).","journal-title":"Scand. J. Rheumatol. Suppl."},{"key":"1057_CR142","doi-asserted-by":"publisher","first-page":"424","DOI":"10.7326\/0003-4819-88-3-424","volume":"88","author":"VN Slee","year":"1978","unstructured":"Slee, V. N. The International Classification of Diseases: ninth revision (ICD-9). Ann. Intern. Med. 88, 424\u2013426 (1978).","journal-title":"Ann. Intern. Med."},{"key":"1057_CR143","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1136\/ard.2003.014027","volume":"63","author":"M Pleisivicnik","year":"2004","unstructured":"Pleisivicnik, M. et al. Incidence of primary Sjogren\u2019s syndrome in Slovenia. Ann. Rheum. Dis. 63, 874\u2013876 (2004).","journal-title":"Ann. Rheum. Dis."},{"key":"1057_CR144","first-page":"2376","volume":"24","author":"G Valesini","year":"1997","unstructured":"Valesini, G. et al. Differential risk of non-Hodgkin\u2019s lymphoma in Italian patients with primary Sj\u00f6gren\u2019s syndrome. J. Rheumatol. 24, 2376\u20132380 (1997).","journal-title":"J. Rheumatol."},{"key":"1057_CR145","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/ard.60.5.467","volume":"60","author":"M Pertovaara","year":"2001","unstructured":"Pertovaara, M., Pukkala, E., Laippala, P., Miettinen, A. & Pasternack, A. A longitudinal cohort study of Finnish patients with primary Sj\u00f6gren\u2019s syndrome: clinical, immunological, and epidemiological aspects. Ann. Rheum. Dis. 60, 467\u2013472 (2001).","journal-title":"Ann. Rheum. Dis."},{"key":"1057_CR146","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1136\/annrheumdis-2011-200402","volume":"71","author":"M-Y Weng","year":"2012","unstructured":"Weng, M.-Y., Huang, Y.-T., Liu, M.-F. & Lu, T.-H. Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren\u2019s syndrome in Taiwan. Ann. Rheum. Dis. 71, 524\u2013527 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"1057_CR147","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00296-019-04433-2","volume":"39","author":"M Brom","year":"2019","unstructured":"Brom, M., Moyano, S., Gandino, I. J., Scolnik, M. & Soriano, E. R. Incidence of cancer in a cohort of patients with primary Sj\u00f6gren syndrome in Argentina. Rheumatol. Int. 39, 1697\u20131702 (2019).","journal-title":"Rheumatol. Int."},{"key":"1057_CR148","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/1756-185X.13927","volume":"23","author":"J Kang","year":"2020","unstructured":"Kang, J. et al. Risk of malignancy in Korean patients with primary Sj\u00f6gren\u2019s syndrome. Int. J. Rheum. Dis. 23, 1240\u20131247 (2020).","journal-title":"Int. J. Rheum. Dis."},{"key":"1057_CR149","first-page":"591","volume":"18","author":"A Finckh","year":"2022","unstructured":"Finckh, A. et al. Global epidemiology of rheumatoid arthritis. Nat. Rev. Rheumatol. 18, 591\u2013602 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1057_CR150","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","volume":"17","author":"MRW Barber","year":"2021","unstructured":"Barber, M. R. W. et al. Global epidemiology of systemic lupus erythematosus. Nat. Rev. Rheumatol. 17, 515\u2013532 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1057_CR151","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1093\/rheumatology\/keab190","volume":"60","author":"M Bairkdar","year":"2021","unstructured":"Bairkdar, M. et al. Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis. Rheumatology 60, 3121\u20133133 (2021).","journal-title":"Rheumatology"}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-023-01057-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-023-01057-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-023-01057-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T09:04:34Z","timestamp":1709024674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-023-01057-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,18]]},"references-count":151,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["1057"],"URL":"https:\/\/doi.org\/10.1038\/s41584-023-01057-6","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,18]]},"assertion":[{"value":"7 November 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.M. has received consulting fees from Bristol Myers Squibb, Horizon, iCell, Kiniksa, Novartis, Otsuka, Target RWE and Visterra. X.M. has received consulting fees from Astra Zeneca, Bristol Myers Squibb, Galapagos, GSK, Novartis and Pfizer. R.S. has received consulting fees from Amgen, Bristol Myers Squibb, Boehringer, GSK, Janssen and Pfizer, and travel fees from Amgen and GSK. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}